NCT00417833终止2 期
Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment
Asociación para Evitar la Ceguera en México0 个研究点开始时间: 2005年12月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 发起方
研究概览
简要总结
Purpose: Determine the short-term safety of intravitreal bevacizumab by multifocal electroretinography (mf-ERG).
Methods: 120 eyes with choroidal neovascularization, proliferative diabetic retinopathy and retinal vein occlusion received intravitreal bevacizumab (2.5mg/0.1cc). All patients underwent best corrected visual acuity, fluorescein angiography, optical coherent tomography and mf-ERG before and 1 month after treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Proliferative diabetic retinopathy, vascular vein oclussion, choroidal neovascularization
- •Multifocal electroretinogram before intravitreal bevacizumab and at 1,3, and 6 months after treatment
- •Completely studies
排除标准
- •Complications
- •Tractional Detachment
- •Endophthalmitis
研究者
相似试验
招募中
4 期
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular EdemaRetinal NeovascularizationMacular EdemaNCT03211741University Hospital, Ghent500
已完成
4 期
Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular DegenerationAge Related Macular DegenerationNCT00556348Instituto de Olhos de Goiania500
Unknown
不适用
Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.Stage 2+ or Stage 3+ Retinopathy of Prematurity in Zone I or Zone II.NCT01707745Sivakami A Pai50
已完成
不适用
Bevacizumab Treatment and Retinal Vessel MonitoringCancerNCT00740168Technische Universität Dresden20
已完成
4 期
Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic RetinopathyProliferative Diabetic RetinopathyDiabetic Traction Retinal DetachmentVitreous HemorrhageNCT01854593Nihon University69